Ghost Tree Capital, LLC Blueprint Medicines Corp Transaction History

Ghost Tree Capital, LLC

$267 Million
Q3 2024

A detailed history of Ghost Tree Capital, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 140,000 shares of BPMC stock, worth $18.1 Million. This represents 4.85% of its overall portfolio holdings.

Number of Shares

140,000

Previous 40,000 250.0%

Holding current value

$18.1 Million

Previous $4.31 Million 200.26%

% of portfolio

4.85%

Previous 1.76%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $8.41 Million - $12.1 Million	100,000 Added 250.0%	140,000 $12.9 Million
Q2 2024 Aug 14, 2024	SELL	$85.18 - $108.78 $2.79 Million - $3.56 Million	-32,761 Reduced 45.03%	40,000 $4.31 Million
Q1 2024 May 15, 2024	BUY	$73.17 - $99.79 $5.32 Million - $7.26 Million	72,761 New	72,761 $6.9 Million
Q4 2022 Feb 14, 2023	SELL	$41.06 - $66.48 $1.85 Million - $2.99 Million	-45,000 Reduced 69.23%	20,000 $876,000
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $3.25 Million - $5.05 Million	65,000 New	65,000 $4.28 Million
Q1 2020 May 15, 2020	SELL	$48.11 - $82.22 $7.22 Million - $12.3 Million	-150,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$66.73 - $82.59 $11.7 Million - $14.5 Million	-175,000 Reduced 53.85%	150,000 $12 Million
Q3 2019 Nov 14, 2019	SELL	$72.9 - $101.41 $3.65 Million - $5.07 Million	-50,000 Reduced 13.33%	325,000 $23.9 Million
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $9.93 Million - $13.2 Million	135,000 Added 56.25%	375,000 $35.4 Million
Q1 2019 May 15, 2019	BUY	$48.7 - $86.6 $11.7 Million - $20.8 Million	240,000 New	240,000 $19.2 Million
Q2 2018 Aug 14, 2018	SELL	$60.96 - $101.18 $7.32 Million - $12.1 Million	-120,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$73.28 - $102.95 $2.2 Million - $3.09 Million	-30,000 Reduced 20.0%	120,000 $11 Million
Q4 2017 Feb 14, 2018	BUY	$62.91 - $88.32 $9.44 Million - $13.2 Million	150,000	150,000 $11.3 Million

Others Institutions Holding BPMC

# of Institutions

379

Shares Held

67.9M

Call Options Held

1.54M

Put Options Held

1.21M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.73B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Account

Ghost Tree Capital, LLC Blueprint Medicines Corp Transaction History